๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and -2 in hepatocellular carcinoma

โœ Scribed by Li Zhou; Yoshitake Hayashi; Takashi Itoh; Weiping Wang; Jing an Rui; Hiroshi Itoh

Book ID
114430983
Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
575 KB
Volume
50
Category
Article
ISSN
1320-5463

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Expression of urokinase-type plasminogen
Expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in colon disease
โœ Slobodan Miseljic; Susan Galandiuk; Stephen D. Myers; Dr. James L. Wittliff ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 488 KB ๐Ÿ‘ 1 views

Surveillance colonoscopy and biopsy are inaccurate methods of predicting the likelihood of ulcerative colitis patients to develop colon carcinoma. We examined uPA and PAI-1 as potential markers for assessing these patients and those with familial polyposis who are at risk of developing colon cancer.

Urokinase plasminogen activator and urok
Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer
โœ C. Duggan; T. Maguire; E. McDermott; N. O'Higgins; J. J. Fennelly; M. J. Duffy ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 385 KB ๐Ÿ‘ 1 views

Urokinase plasminogen activator (uPA) is a serine protease involved in cancer invasion and metastasis. uPA mediates its action while attached to a membrane-bound receptor (uPAR). In this investigation we show that uPAR levels correlate with uPA levels in human breast cancers. uPAR levels, however, d